GP120 Produkte
(Human Immunodeficiency Virus 1 Surface Glycoprotein (HIV-1 gp120))
Kategorien
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte GP120 Kategorien
GP120 Antikörper
High quality antibodies with extensive validation data.
GP120 Proteine
Proteins for various applications incl. WB, ELISA, IF etc.
Empfohlene GP120 Antikörper
- (1)
- (1)
- (2)
Empfohlene GP120 Proteine
- (1)
Neueste Publikationen zu unseren GP120 Produkten
: "HIV-1 adaptation studies reveal a novel Env-mediated homeostasis mechanism for evading lethal hypermutation by APOBEC3G." in: PLoS pathogens, Vol. 14, Issue 4, pp. e1007010, (2018) (PubMed).: "Enabling electrical biomolecular detection in high ionic concentrations and enhancement of the detection limit thereof by coupling a nanofluidic crystal with reconfigurable ion concentration ..." in: Lab on a chip, Vol. 17, Issue 22, pp. 3772-3784, (2018) (PubMed).
: "SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef." in: Nature, Vol. 526, Issue 7572, pp. 218-23, (2016) (PubMed).
: "Intercellular adhesion molecule 1 promotes HIV-1 attachment but not fusion to target cells." in: PLoS ONE, Vol. 7, Issue 9, pp. e44827, (2013) (PubMed).
: "The membrane-spanning domain of gp41 plays a critical role in intracellular trafficking of the HIV envelope protein." in: Retrovirology, Vol. 7, pp. 95, (2010) (PubMed).
: "Mapping the immune response to the outer domain of a human immunodeficiency virus-1 clade C gp120." in: The Journal of general virology, Vol. 89, Issue Pt 10, pp. 2597-604, (2008) (PubMed).
: "HIV coreceptors: from discovery and designation to new paradigms and promise." in: European journal of medical research, Vol. 12, Issue 9, pp. 375-84, (2007) (PubMed).
: "Roles of HIV-1 Env variable regions in viral neutralization and vaccine development." in: Current HIV research, Vol. 5, Issue 6, pp. 542-53, (2007) (PubMed).